STOCK TITAN

Sensus Healthcare (SRTS) director adds 31K shares

(Neutral)
(Positive)
Form Type
4

Rhea-AI Filing Summary

Sensus Healthcare, Inc. (SRTS) director Eric Sachetta reported open-market purchases of 31,000 shares of common stock. He bought 24,000 shares on August 20, 2026 at $3.1280 per share and 7,000 shares on August 21, 2026 at $3.2540 per share, all held directly. A separate entry shows 2,093 shares held indirectly through his spouse. The filing indicates these transactions were not made pursuant to a Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.
Insider Sachetta Eric
Role Director
Bought 31,000 shs ($98K)
Type Security Shares Price Value
Purchase Common Stock 7,000 $3.254 $23K
Purchase Common Stock 24,000 $3.128 $75K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 174,613 shares (Direct); Common Stock — 2,093 shares (Indirect, Spouse)
Shares purchased August 20, 2026 24,000 shares Open-market purchase of Sensus Healthcare common stock at $3.1280 per share
Purchase price August 20, 2026 $3.1280 per share Price for 24,000 SRTS common shares bought by Eric Sachetta
Shares purchased August 21, 2026 7,000 shares Open-market purchase of Sensus Healthcare common stock at $3.2540 per share
Purchase price August 21, 2026 $3.2540 per share Price for 7,000 SRTS common shares bought by Eric Sachetta
Total shares bought 31,000 shares Transaction summary buyShares across both reported purchases
Indirectly held shares (spouse) 2,093 shares Indirect ownership entry with nature of ownership Spouse
open market or private transaction market
"transaction_code_description: Purchase in open market or private transaction"
indirect ownership financial
"ownership_type: indirect, nature_of_ownership: Spouse"
Rule 10b5-1 trading plan regulatory
"aff_10b5_one indicates the Rule 10b5-1 checkbox status"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

FAQ

What insider transactions did SRTS director Eric Sachetta report on this Form 4?

He reported open-market purchases of 31,000 SRTS common shares, consisting of 24,000 shares on August 20, 2026 at $3.1280 per share and 7,000 shares on August 21, 2026 at $3.2540 per share, all held directly.

At what prices did Eric Sachetta buy Sensus Healthcare (SRTS) shares?

He purchased 24,000 shares at $3.1280 per share on August 20, 2026 and 7,000 shares at $3.2540 per share on August 21, 2026, in open-market or private transactions as indicated by transaction code P.

How many SRTS shares did Eric Sachetta buy in total in this Form 4?

The Form 4 transaction summary shows total buyShares of 31,000, reflecting two reported open-market purchase transactions of Sensus Healthcare common stock.

Does Eric Sachetta have any indirect ownership of Sensus Healthcare (SRTS) shares?

Yes. The filing lists an indirect holding of 2,093 SRTS common shares, with the nature of ownership described as Spouse, indicating shares held through his spouse.

Were Eric Sachetta’s SRTS share purchases made under a Rule 10b5-1 trading plan?

No. The Rule 10b5-1 checkbox in the filing is not checked (aff_10b5_one is false), indicating these reported purchases were not executed pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sachetta Eric

(Last)(First)(Middle)
851 BROKEN SOUND PARKWAY NW #215

(Street)
BOCA RATON FLORIDA 33487

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Sensus Healthcare, Inc. [ SRTS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/20/2026P24,000A$3.128167,613D
Common Stock08/21/2026P7,000A$3.254174,613D
Common Stock2,093ISpouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ /s/ Eric Sachetta08/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)